CRT 25 - Outcomes in patients with intermediate-risk pulmonary embolism (PE) with contraindications to thrombolytics show large-bore mechanical thrombectomy is a safe and effective treatment option for this comorbid patient population. In the contraindication cohort, large-bore mechanical thrombectomy was successfully performed with no in-hospital mortality or intracranial haemorrhage.

Dr Stefan Stortecky (Bern University Hospital, Bern, CH) joins us to discuss outcomes from a parallel, non-randomized registry from the PEERLESS (NCT05111613) cohort. The contraindication cohort investigated large-bore mechanical thrombectomy with the FlowTriever system for intermediate-risk PE in patients with contraindications to thrombolytic therapy. 

Interview Questions:
1. What is the reasoning behind the study?
2. What was the study design and patient population?
3. What were the key findings?
4. What are the take-home messages for practice?
5. What further research is needed in this area?

Recorded remotely from Bern, 2025.

Editors: Yazmin Sadik, Jordan Rance
Videographers: Dan Brent, David Ben-Harosh

Support: This is an independent interview produced by Radcliffe Vascular.